Alaunos Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
TCRT Company Description
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
TCRT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view TCRT Smart Score
Score Breakdown
TCRT Company Description
Show More
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of TCRT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TCRT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of TCRT in WallStreetBets Daily Discussion
TCRT News
Recent insights relating to TCRT
CNBC Recommendations
Recent picks made for TCRT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in TCRT
Corporate Flights
Flights by private jets registered to TCRT
Our Analysis